TAKEDA PHARMACEUTICAL CO LTD's ticker is and the CUSIP is 874060955. A total of 2 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,494 | +362.6% | 20,200 | +369.8% | 0.00% | – |
| Q2 2023 | $67,553 | -6.8% | 4,300 | -2.3% | 0.00% | – |
| Q1 2023 | $72,512 | -85.0% | 4,400 | -85.8% | 0.00% | -100.0% |
| Q4 2022 | $483,600 | -29.9% | 31,000 | -41.7% | 0.00% | 0.0% |
| Q3 2022 | $690,000 | -46.9% | 53,200 | -42.5% | 0.00% | -50.0% |
| Q2 2022 | $1,299,000 | -7.1% | 92,500 | -5.3% | 0.00% | +100.0% |
| Q1 2022 | $1,399,000 | -27.7% | 97,700 | -31.1% | 0.00% | -50.0% |
| Q4 2021 | $1,934,000 | +44.7% | 141,900 | +73.9% | 0.00% | +100.0% |
| Q3 2021 | $1,337,000 | -60.7% | 81,600 | -59.6% | 0.00% | -75.0% |
| Q2 2021 | $3,403,000 | -65.9% | 202,200 | -63.0% | 0.00% | -73.3% |
| Q1 2021 | $9,985,000 | +339.3% | 546,800 | +337.8% | 0.02% | +275.0% |
| Q4 2020 | $2,273,000 | +10.0% | 124,900 | +7.9% | 0.00% | -33.3% |
| Q3 2020 | $2,066,000 | -0.0% | 115,800 | +0.4% | 0.01% | -40.0% |
| Q2 2020 | $2,067,000 | +187.9% | 115,300 | +143.8% | 0.01% | +66.7% |
| Q1 2020 | $718,000 | -5.0% | 47,300 | +23.5% | 0.01% | +20.0% |
| Q4 2019 | $756,000 | +87.1% | 38,300 | +63.0% | 0.01% | +66.7% |
| Q3 2019 | $404,000 | -41.8% | 23,500 | -40.1% | 0.00% | -50.0% |
| Q2 2019 | $694,000 | +230.5% | 39,200 | +280.6% | 0.01% | +200.0% |
| Q1 2019 | $210,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 20,200 | $312,494 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |